Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Erratum to: The loop-less tmCdc34 E2 mutant defective polyubiquitination in vitro and in vivo supports yeast growth in a manner dependent on Ubp14 and Cka2.

Lass A, Cocklin R, Scaglione KM, Skowyra M, Korolev S, Goebl M, Skowyra D.

Cell Div. 2016 Oct 6;11:13. doi: 10.1186/s13008-016-0018-1. eCollection 2016.

2.

SIMPL enhancement of tumor necrosis factor-α dependent p65-MED1 complex formation is required for mammalian hematopoietic stem and progenitor cell function.

Zhao W, Breese E, Bowers A, Hoggatt J, Pelus LM, Broxmeyer HE, Goebl M, Harrington MA.

PLoS One. 2013 Apr 22;8(4):e61123. doi: 10.1371/journal.pone.0061123. Print 2013.

3.

Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth.

Adler JJ, Heller BL, Bringman LR, Ranahan WP, Cocklin RR, Goebl MG, Oh M, Lim HS, Ingham RJ, Wells CD.

J Biol Chem. 2013 May 24;288(21):15181-93. doi: 10.1074/jbc.M112.446534. Epub 2013 Apr 5.

4.

Nutrient sensing kinases PKA and Sch9 phosphorylate the catalytic domain of the ubiquitin-conjugating enzyme Cdc34.

Cocklin R, Goebl M.

PLoS One. 2011;6(11):e27099. doi: 10.1371/journal.pone.0027099. Epub 2011 Nov 7.

5.

The loop-less tmCdc34 E2 mutant defective in polyubiquitination in vitro and in vivo supports yeast growth in a manner dependent on Ubp14 and Cka2.

Lass A, Cocklin R, Scaglione KM, Skowyra M, Korolev S, Goebl M, Skowyra D.

Cell Div. 2011 Mar 31;6:7. doi: 10.1186/1747-1028-6-7. Erratum in: Cell Div. 2016 Oct 6;11:13.

6.

New insight into the role of the Cdc34 ubiquitin-conjugating enzyme in cell cycle regulation via Ace2 and Sic1.

Cocklin R, Heyen J, Larry T, Tyers M, Goebl M.

Genetics. 2011 Mar;187(3):701-15. doi: 10.1534/genetics.110.125302. Epub 2010 Dec 31.

7.

The antibiotic gentamicin inhibits specific protein trafficking functions of the Arf1/2 family of GTPases.

Lin L, Wagner MC, Cocklin R, Kuzma A, Harrington M, Molitoris BA, Goebl MG.

Antimicrob Agents Chemother. 2011 Jan;55(1):246-54. doi: 10.1128/AAC.00450-10. Epub 2010 Oct 18.

8.

Loss of SIMPL compromises TNF-alpha-dependent survival of hematopoietic progenitors.

Benson EA, Goebl MG, Yang FC, Kapur R, McClintick J, Sanghani S, Clapp DW, Harrington MA.

Exp Hematol. 2010 Feb;38(2):71-81. doi: 10.1016/j.exphem.2009.11.006. Epub 2009 Nov 23.

9.

Identification, analysis, and prediction of protein ubiquitination sites.

Radivojac P, Vacic V, Haynes C, Cocklin RR, Mohan A, Heyen JW, Goebl MG, Iakoucheva LM.

Proteins. 2010 Feb 1;78(2):365-80. doi: 10.1002/prot.22555.

10.

Transient membrane recruitment of IRAK-1 in response to LPS and IL-1beta requires TNF R1.

Lockett A, Goebl MG, Harrington MA.

Am J Physiol Cell Physiol. 2008 Aug;295(2):C313-23. doi: 10.1152/ajpcell.00500.2007. Epub 2008 Jun 18.

11.

Selective inhibition of platelets by the GPIIb/IIIa receptor antagonist Tirofiban reduces leukocyte-endothelial cell interaction in murine antigen-induced arthritis.

Schmitt-Sody M, Metz P, Gottschalk O, Zysk S, Birkenmaier C, Goebl M, von Schulze Pellengahr C, Veihelmann A, Jansson V.

Inflamm Res. 2007 Oct;56(10):414-20.

PMID:
18026698
12.

SCF E3-mediated autoubiquitination negatively regulates activity of Cdc34 E2 but plays a nonessential role in the catalytic cycle in vitro and in vivo.

Scaglione KM, Bansal PK, Deffenbaugh AE, Kiss A, Moore JM, Korolev S, Cocklin R, Goebl M, Kitagawa K, Skowyra D.

Mol Cell Biol. 2007 Aug;27(16):5860-70. Epub 2007 Jun 11.

13.

Tumor Necrosis Factor-alpha- and interleukin-1-induced cellular responses: coupling proteomic and genomic information.

Ott LW, Resing KA, Sizemore AW, Heyen JW, Cocklin RR, Pedrick NM, Woods HC, Chen JY, Goebl MG, Witzmann FA, Harrington MA.

J Proteome Res. 2007 Jun;6(6):2176-85. Epub 2007 May 16.

14.

The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging.

Brutkiewicz S, Mendonca M, Stantz K, Comerford K, Bigsby R, Hutchins G, Goebl M, Harrington M.

Luminescence. 2007 May-Jun;22(3):221-8.

PMID:
17286245
15.

Phosphorylation of SIMPL modulates RelA-associated NF-kappaB-dependent transcription.

Luo Y, Kwon HJ, Montano S, Georgiadis M, Goebl MG, Harrington MA.

Am J Physiol Cell Physiol. 2007 Mar;292(3):C1013-23. Epub 2006 Nov 1.

16.

Alpha-lipoic acid modulates ovarian surface epithelial cell growth.

Vig-Varga E, Benson EA, Limbil TL, Allison BM, Goebl MG, Harrington MA.

Gynecol Oncol. 2006 Oct;103(1):45-52. Epub 2006 Mar 29.

PMID:
16574204
18.

The ubiquitin ligase SCFGrr1 is necessary for pheromone sensitivity in Saccharomyces cerevisiae.

Schweitzer K, Cocklin R, Garrett L, Desai F, Goebl M.

Yeast. 2005 May;22(7):553-64.

19.

Tumor necrosis factor alpha induction of NF-kappaB requires the novel coactivator SIMPL.

Kwon HJ, Breese EH, Vig-Varga E, Luo Y, Lee Y, Goebl MG, Harrington MA.

Mol Cell Biol. 2004 Nov;24(21):9317-26.

20.

Necessity's sharp pinch.

Chun KT, Goebl MG.

Mol Cell. 2004 Jul 23;15(2):166-8.

21.
22.

Cutting edge: mouse pellino-2 modulates IL-1 and lipopolysaccharide signaling.

Yu KY, Kwon HJ, Norman DA, Vig E, Goebl MG, Harrington MA.

J Immunol. 2002 Oct 15;169(8):4075-8.

23.

Overexpression of a stabilized mutant form of the cyclin-dependent kinase inhibitor p27(Kip1) inhibits cell growth.

Hurteau JA, Brutkiewicz SA, Wang Q, Allison BM, Goebl MG, Harrington MA.

Gynecol Oncol. 2002 Jul;86(1):19-23.

PMID:
12079294
24.

Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.

Hurteau JA, Allison BM, Brutkiewicz SA, Goebl MG, Heilman DK, Bigsby RM, Harrington MA.

Gynecol Oncol. 2001 Nov;83(2):292-8.

PMID:
11606087
25.

SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-kappaB activity.

Vig E, Green M, Liu Y, Yu KY, Kwon HJ, Tian J, Goebl MG, Harrington MA.

J Biol Chem. 2001 Mar 16;276(11):7859-66. Epub 2000 Nov 28.

26.

The abundance of Met30p limits SCF(Met30p) complex activity and is regulated by methionine availability.

Smothers DB, Kozubowski L, Dixon C, Goebl MG, Mathias N.

Mol Cell Biol. 2000 Nov;20(21):7845-52.

27.
28.

Modulation of tumor necrosis factor and interleukin-1-dependent NF-kappaB activity by mPLK/IRAK.

Vig E, Green M, Liu Y, Donner DB, Mukaida N, Goebl MG, Harrington MA.

J Biol Chem. 1999 May 7;274(19):13077-84.

29.
30.

Phosphorylation of nuclear MyoD is required for its rapid degradation.

Song A, Wang Q, Goebl MG, Harrington MA.

Mol Cell Biol. 1998 Sep;18(9):4994-9.

31.

Modification of yeast Cdc53p by the ubiquitin-related protein rub1p affects function of the SCFCdc4 complex.

Lammer D, Mathias N, Laplaza JM, Jiang W, Liu Y, Callis J, Goebl M, Estelle M.

Genes Dev. 1998 Apr 1;12(7):914-26.

32.
33.
34.

Rapid amplification of uncharacterized transposon-tagged DNA sequences from genomic DNA.

Chun KT, Edenberg HJ, Kelley MR, Goebl MG.

Yeast. 1997 Mar 15;13(3):233-40.

35.

Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins.

Mathias N, Johnson SL, Winey M, Adams AE, Goetsch L, Pringle JR, Byers B, Goebl MG.

Mol Cell Biol. 1996 Dec;16(12):6634-43.

36.

SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW, Elledge SJ.

Cell. 1996 Jul 26;86(2):263-74.

37.

Developmental and tissue-specific expression of mouse pelle-like protein kinase.

Trofimova M, Sprenkle AB, Green M, Sturgill TW, Goebl MG, Harrington MA.

J Biol Chem. 1996 Jul 26;271(30):17609-12.

39.

Identification of a positive regulator of the cell cycle ubiquitin-conjugating enzyme Cdc34 (Ubc3).

Prendergast JA, Ptak C, Kornitzer D, Steussy CN, Hodgins R, Goebl M, Ellison MJ.

Mol Cell Biol. 1996 Feb;16(2):677-84.

40.

Ubiquitin-dependent proteolysis and cell cycle control in yeast.

Chun KT, Mathias N, Goebl MG.

Prog Cell Cycle Res. 1996;2:115-27. Review.

PMID:
9552389
42.

Requirement of the self-glucosylating initiator proteins Glg1p and Glg2p for glycogen accumulation in Saccharomyces cerevisiae.

Cheng C, Mu J, Farkas I, Huang D, Goebl MG, Roach PJ.

Mol Cell Biol. 1995 Dec;15(12):6632-40.

43.
44.

Comparative genomics, genome cross-referencing and XREFdb.

Bassett DE Jr, Boguski MS, Spencer F, Reeves R, Goebl M, Hieter P.

Trends Genet. 1995 Sep;11(9):372-3. No abstract available.

PMID:
7482790
45.
46.

The identification of a gene family in the Saccharomyces cerevisiae ergosterol biosynthesis pathway.

Lai MH, Bard M, Pierson CA, Alexander JF, Goebl M, Carter GT, Kirsch DR.

Gene. 1994 Mar 11;140(1):41-9.

PMID:
8125337
47.

A novel gene, STT4, encodes a phosphatidylinositol 4-kinase in the PKC1 protein kinase pathway of Saccharomyces cerevisiae.

Yoshida S, Ohya Y, Goebl M, Nakano A, Anraku Y.

J Biol Chem. 1994 Jan 14;269(2):1166-72.

48.

Yeast bZip proteins mediate pleiotropic drug and metal resistance.

Wu A, Wemmie JA, Edgington NP, Goebl M, Guevara JL, Moye-Rowley WS.

J Biol Chem. 1993 Sep 5;268(25):18850-8.

49.

Localization of Drosophila retinal degeneration B, a membrane-associated phosphatidylinositol transfer protein.

Vihtelic TS, Goebl M, Milligan S, O'Tousa JE, Hyde DR.

J Cell Biol. 1993 Sep;122(5):1013-22.

50.

Molecular cloning of a human homologue of Drosophila heterochromatin protein HP1 using anti-centromere autoantibodies with anti-chromo specificity.

Saunders WS, Chue C, Goebl M, Craig C, Clark RF, Powers JA, Eissenberg JC, Elgin SC, Rothfield NF, Earnshaw WC.

J Cell Sci. 1993 Feb;104 ( Pt 2):573-82.

Supplemental Content

Support Center